Oncologic results, functional outcomes, and complication rates of transperitoneal robotic assisted radical prostatectomy: Single centre's experience

Ihsan-Tasci, A.; Şimşek, Abdülmuttalip; Dogukan-Torer, M.B.; Sökmen, Doğukan; Şahin, Selçuk; Bitkin, Alper; Tuğcu, Volkan

doi:10.1016/j.acuroe.2015.01.001

Cited by 4 publications

(7 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We have sufficient follow-up to compare the outcomes of prostate cancer patients. Individually speaking, strictly regarding continence, our results are superior to those of the series by Patel et al 10 (96%), Ou et al 12 (98%), and Ihsan-Tasci et al 6 (96%). Regarding the rates of complication and the oncological outcomes reported (positive surgical margins and biochemical recurrence-free rates), our results are within the average of the series provided by Anastasis et al 9 , and Gárate et al 13 .…”

Section: Discussioncontrasting

confidence: 51%

“…Radical prostatectomy as a therapeutic option for managing prostate cancer can be performed using open, laparoscopic, or robot-assisted approaches, being oncological outcomes very similar. However, there are significant differences in terms of functional outcomes and perioperative complications that favor robot-assisted surgery, making it a safer, more effective alternative with better satisfaction rates reflected in the patients' quality of life 6,7 .…”

Section: Introductionmentioning

confidence: 99%

“…In the last decade, various groups have tried to demonstrate the safety and efficacy profile of RARP with various associated technique variants (anterior, posterior, lateral, nerve-sparing, etc.) based on the pentafecta concept, making robot-assisted surgery the best option to achieve oncological control and optimize the quality of life of patients with prostate cancer 6,[12][13][14] .…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Pentafecta evaluation in robot-assisted radical prostatectomy by risk group

Corona-Montes,

Sánchez-Núñez,

Gómez-López

et al. 2024

CIRUE

View full text Add to dashboard Cite

Objetivo: Radical prostatectomy is a therapeutic option in organ-confined prostate cancer. As the development of robotic systems progresses, the approach with this technology has begun to impact the functional and oncological outcomes of urological patients. The objective is to report the rate of pentafecta in patients undergoing robot-assisted radical prostatectomy (RARP) stratified by risk groups. Method: Retrospective, observational, descriptive study from 2013 to 2020 that included 112 patients undergoing RARP. Results: A rate of pentafecta at 12 months of follow-up of 35.7% (n = 40) was obtained. In the subanalysis by risk groups, at 1-year follow-up, was obtained an index of 43% (n = 26), 26% (n = 9) and 22% (n = 4) in low-, intermediate-, and high-risk patients, respectively. Conclusions: Prostatectomy showed functional and oncological results similar to those reported in the literature with robotic approach, regardless of the risk group for prostate cancer.

show abstract

Section: Discussioncontrasting

confidence: 51%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Pentafecta evaluation in robot-assisted radical prostatectomy by risk group

Corona-Montes,

Sánchez-Núñez,

Gómez-López

et al. 2024

CIRUE

View full text Add to dashboard Cite

show abstract

“…La prostatectomía radical como opción terapéutica para el manejo del cáncer de próstata puede ser realizada mediante técnica abierta, abordaje laparoscópico y abordaje asistido por robot; los resultados oncológicos son muy similares, lo cual es el desenlace primario deseado en el manejo de los pacientes con cáncer de próstata. Sin embargo, existen diferencias significativas en cuanto a los desenlaces funcionales y las complicaciones perioperatorias que favorecen a la cirugía asistida por robot, convirtiéndola en una alternativa más segura, eficaz y con mejores tasas de satisfacción reflejadas en la calidad de vida de los pacientes 6,7 .…”

Section: Introductionunclassified

“…En la última década, diversos grupos han buscado demostrar la eficacia y la seguridad de la PRAR con diversas variantes asociadas a la técnica (abordaje anterior, posterior, lateral, neuropreservador, etc.) con base en el concepto de pentafecta, convirtiendo la técnica asistida por robot como la mejor alternativa para conseguir el control oncológico y optimizar la calidad de vida de los pacientes con cáncer de próstata 6,[12][13][14] .…”

Section: Introductionunclassified

Evaluación de pentafecta en prostatectomia radical asistida por robot por grupo de riesgo

Corona-Montes,

Sánchez-Núñez,

Gómez-López

et al. 2024

CIRU

View full text Add to dashboard Cite

Objetivo: La prostatectomía radical es la alternativa terapéutica de elección en el cáncer de próstata confinado al órgano. Conforme avanza el desarrollo de los sistemas robóticos, el abordaje con esta tecnología ha comenzado a impactar en los desenlaces funcionales y oncológicos de los pacientes urológicos. El objetivo es reportar el índice de pentafecta en pacientes sometidos a prostatectomía radical asistida por robot (PRRA) estratificados por grupos de riesgo. Método: Estudio retrospectivo, observacional, descriptivo, de 2013 a 2020, que incluyó 112 pacientes sometidos a PRAR. Resultados: Se obtuvo un índice de pentafecta a 12 meses de seguimiento del 35.7% (n = 40). En el subanálisis por grupos de riesgo, al año de seguimiento, se obtuvieron unos índices del 43% (n = 26), el 26% (n = 9) y el 22% (n = 4) en los pacientes de bajo, intermedio y alto riesgo, respectivamente. Conclusiones: La prostatectomía demostró resultados funcionales y oncológicos similares a lo reportado en la literatura con abordaje robótico independientemente del grupo de riesgo del cáncer de próstata.

show abstract

Intrafascial versus interfascial nerve sparing in radical prostatectomy for localized prostate cancer: a systematic review and meta-analysis

Weng

Zeng

Sheng

et al. 2017

Sci Rep

View full text Add to dashboard Cite

The present study aimed to systematically evaluate the effectiveness and safety of the intrafascial and interfascial nerve sparing (ITR-NS and ITE-NS) radical prostatectomy. PubMed, Embase, and Cochrane Library databases were searched for eligible studies. Meta-analysis with random-effects model was performed. Six comparative trials were selected and embraced in this research, including one randomized controlled trial, three prospective comparative trials, and two retrospective comparative trials. With regard to perioperative parameters, no significant association of operative time, blood loss, transfusion rates, duration of catheterization, and hospital stay existed between ITR-NS and ITE-NS. With respect to the functional results, ITR-NS had advantages in terms of both continence and potency recovery compared with ITE-NS. In reference to the oncologic results, the ITR-NS showed lower overall positive surgical margin (PSM) compared with ITE-NS but pT2 PSM and biochemical recurrence free rates were similar to the two surgical types. This study demonstrates that ITR-NS has better continence at 6 mo and 36 mo and better potency recovery at 6 mo and 12 mo postoperatively, regardless of the surgical technique. The cancer control of ITR-NS was also better than that of ITE-NS. This may be explained by the fact that patients in ITE-NS group present higher risk cancer than patients in ITR-NS group.

show abstract

Oncologic results, functional outcomes, and complication rates of transperitoneal robotic assisted radical prostatectomy: Single centre's experience

Cited by 4 publications

References 30 publications

Pentafecta evaluation in robot-assisted radical prostatectomy by risk group

Pentafecta evaluation in robot-assisted radical prostatectomy by risk group

Evaluación de pentafecta en prostatectomia radical asistida por robot por grupo de riesgo

Intrafascial versus interfascial nerve sparing in radical prostatectomy for localized prostate cancer: a systematic review and meta-analysis

Contact Info

Product

Resources

About